Vanguard Group Inc Neuro Bo Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.36 - $123.84 $177,838 - $61.2 Million	-493,995 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.72 - $1.54 $433 - $927	-602 Reduced 0.12%	493,995 $445,000
Q3 2021 Nov 12, 2021	BUY	$2.73 - $4.52 $45,533 - $75,389	16,679 Added 3.49%	494,597 $1.84 Million
Q2 2021 Aug 13, 2021	BUY	$2.74 - $4.63 $1.31 Million - $2.21 Million	477,918 New	477,918 $1.59 Million

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.